Corbenic Partners’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-100
Closed -$4K 229
2017
Q3
$4K Hold
100
0.01% 209
2017
Q2
$4K Hold
100
0.01% 141
2017
Q1
$3K Hold
100
﹤0.01% 167
2016
Q4
$3K Hold
100
﹤0.01% 175
2016
Q3
$3K Hold
100
﹤0.01% 170
2016
Q2
$2K Hold
100
﹤0.01% 165
2016
Q1
$3K Hold
100
﹤0.01% 149
2015
Q4
$3K Buy
+100
New +$3.21K ﹤0.01% 163

Other funds holding PAHC

Corbenic Partners's PAHC Position: Q4 2017 in Review

Corbenic Partners sold out of Phibro Animal Health (PAHC) in Q4 2017, closing a stake of 100 shares — an estimated $4K sold.

Corbenic Partners first reported a position in PAHC in Q4 2015 and held it in 8 quarters. The position peaked at $4K in Q3 2017. 169 funds tracked by Wall St. Rank hold PAHC as of Q4 2017.

  • Corbenic Partners reported no remaining Phibro Animal Health position as of Q4 2017 after selling out during the quarter.
  • Corbenic Partners sold 100 Phibro Animal Health shares in Q4 2017, an estimated $4K.
  • Corbenic Partners first reported a position in Phibro Animal Health in Q4 2015 and held it in 8 quarters.
  • Corbenic Partners's Phibro Animal Health position peaked at $4K in Q3 2017.
  • 169 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2017.

Based on Corbenic Partners's 13F filing for Q4 2017, filed 25 Jan 2018.